E-LIB Suche - Ergebnisse für: Berlin, Suzanne

1

A phase I study of AZD2171 and Temsirolimus in patients wit..:

Campos, Susana M. ; Berlin, Suzanne ; Krasner, Carolyn N....
Cancer Chemotherapy and Pharmacology. 89 (2022) 3 - p. 423-430 , 2022

Link: https://doi.org/10.1007/..

2

A randomized phase II trial of bevacizumab vs. bevacizumab ..:

Campos, Susana ; Matulonis, Ursula ; Berlin, Suzanne...
International Journal of Clinical Oncology. 27 (2022) 12 - p. 1881-1890 , 2022

Link: https://doi.org/10.1007/..

3

Ofranergene obadenovec (VB-111) in platinum-resistant ovari..:

Arend, Rebecca C. ; Beer, Hannah M. ; Cohen, Yael C....
Gynecologic Oncology. 157 (2020) 3 - p. 578-584 , 2020

Link: https://doi.org/10.1016/..

4

Phase I study of combination of vorinostat, carboplatin, an..:

Matulonis, Ursula ; Berlin, Suzanne ; Lee, Hang...
Cancer Chemotherapy and Pharmacology. 76 (2015) 2 - p. 417-423 , 2015

Link: https://doi.org/10.1007/..

5

Molecular Characterization of an Endometrial Endometrioid A..:

Afrogheh, Amir H. ; Meserve, Emily ; Sadow, Peter M....
Endocrine Pathology. 27 (2015) 3 - p. 213-219 , 2015

Link: https://doi.org/10.1007/..

6

A prospective feasibility study of radiation and concurrent..:

Viswanathan, Akila N. ; Lee, Hang ; Berkowitz, Ross...
Gynecologic Oncology. 132 (2014) 1 - p. 55-60 , 2014

Link: https://doi.org/10.1016/..

7

A phase II trial of Sunitinib malate in recurrent and refra..:

Campos, Susana M. ; Penson, Richard T. ; Matulonis, Ursula...
Gynecologic Oncology. 128 (2013) 2 - p. 215-220 , 2013

Link: https://doi.org/10.1016/..

8

Typical and atypical metastatic sites of recurrent endometr..:

Kurra, Vikram ; Krajewski, Katherine M. ; Jagannathan, Jyothi...
Cancer Imaging. 13 (2013) 1 - p. 113-122 , 2013

Link: https://doi.org/10.1102/..

9

Using FastTrack to implement an academic medical center and..:

Waldman, Laura Tesler ; Bean, William ; Levine, Anne L....
Healthcare. 1 (2013) 3-4 - p. 130-135 , 2013

Link: https://doi.org/10.1016/..

10

A novel community-based delivery model to combat cancer dis..:

Waldman, Laura Tesler ; Svoboda, Ludmila ; Young, Brian F....
Healthcare. 1 (2013) 3-4 - p. 123-129 , 2013

Link: https://doi.org/10.1016/..

11

Sequential bevacizumab and oral cyclophosphamide for recurr..:

Matulonis, Ursula A. ; Pereira, Lauren ; Liu, Joyce...
Gynecologic Oncology. 126 (2012) 1 - p. 41-46 , 2012

Link: https://doi.org/10.1016/..

12

Young Women Diagnosed with Early-Stage Ovarian Cancer or Bo..:

Campos, Susana M. ; Berlin, Suzanne ; Matulonis, Ursula A....
Journal of Psychosocial Oncology. 30 (2012) 4 - p. 387-401 , 2012

Link: https://doi.org/10.1080/..

13

Safety, Efficacy, and Biomarker Exploration in a Phase II S..:

Horowitz, Neil S. ; Penson, Richard T. ; Duda, Dan G....
Clinical Ovarian Cancer. 4 (2011) 1 - p. 26-33 , 2011

Link: https://doi.org/10.1016/..

14

Eribulin mesylate (halichondrin B analog E7389) in platinum..:

Hensley, Martee L. ; Kravetz, Sara ; Jia, Xiaoyu...
Cancer. 118 (2011) 9 - p. 2403-2410 , 2011

Link: https://doi.org/10.1002/..

15

Risk stratification and skin testing to guide re-exposure i..:

Picard, Matthieu ; Pur, Leyla ; Caiado, Joana...
Journal of Allergy and Clinical Immunology. 137 (2016) 4 - p. 1154-1164.e12 , 2016

Link: https://doi.org/10.1016/..